Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer

Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer

NCT00143390 ·Status: COMPLETED ·Phase: PHASE3

Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer

NCT00073073 ·Status: COMPLETED ·Phase: PHASE2

Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women

NCT00040014 ·Status: TERMINATED ·Phase: PHASE2

Musculoskeletal Pain in Postmenopausal, Early Breast Cancer Patients Receiving Aromatase Inhibitor Therapy - A Pilot Study

NCT00653718 ·Status: COMPLETED

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane

NCT00036270 ·Status: COMPLETED ·Phase: PHASE3

Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

NCT01431053 ·Status: UNKNOWN ·Phase: PHASE2

Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients

NCT00174343 ·Status: COMPLETED ·Phase: PHASE2

This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.

NCT05439499 ·Status: UNKNOWN ·Phase: PHASE3

A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer

NCT01695226 ·Status: COMPLETED ·Phase: PHASE2

Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer

NCT01237327 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer

NCT00793546 ·Status: TERMINATED ·Phase: PHASE2

Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China

NCT01176916 ·Status: COMPLETED ·Phase: PHASE4

Aromatase Inhibitor Clinical Trial

NCT00228956 ·Status: UNKNOWN

The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer

NCT00065325 ·Status: COMPLETED ·Phase: PHASE3

Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

NCT00031850 ·Status: COMPLETED ·Phase: NA

PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY

NCT03423199 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients

NCT01305239 ·Status: TERMINATED

A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）

NCT03137368 ·Status: UNKNOWN ·Phase: PHASE3

Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen

NCT00016432 ·Status: COMPLETED ·Phase: PHASE3

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

NCT02598557 ·Status: COMPLETED ·Phase: PHASE2

Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer

NCT00573755 ·Status: TERMINATED ·Phase: PHASE2

Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients

NCT02765373 ·Status: UNKNOWN

Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

NCT00316836 ·Status: COMPLETED

Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant

NCT00919399 ·Status: COMPLETED ·Phase: PHASE2